Finance

Lists
OXB:LON
Oxford BioMedica plc
521,00 GBX
+1,56%
(+8,00) 1D
9 ოქტ, 16:35:08 GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for OXB...
Open
513,00 GBX
High
539,00 GBX
Low
513,00 GBX
Mkt. cap
630,67 მლნ.
Avg. vol.
824,14 ათ.
Volume
147,27 ათ.
52-wk high
962,00 GBX
52-wk low
420,00 GBX
EPS
-0,34 GBX
Shares outstanding
121,05 მლნ.
No. of employees
1 ათ.
Open
513,00 GBX
High
539,00 GBX
Low
513,00 GBX
Mkt. cap
630,67 მლნ.
Avg. vol.
824,14 ათ.
Volume
147,27 ათ.
52-wk high
962,00 GBX
52-wk low
420,00 GBX
EPS
-0,34 GBX
Shares outstanding
121,05 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
Profile
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Wikipedia
About Oxford BioMedica plc
CEOფრენკ მათიას
Employees1,02 ათ.
Founded1995
Headquarters-
Sector-
Websiteoxb.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
47,76 მლნ.
47,76 მლნ.
39,92 მლნ.
39,92 მლნ.
Cost of goods sold
30,60 მლნ.
30,60 მლნ.
25,35 მლნ.
25,35 მლნ.
Cost of revenue
30,60 მლნ.
30,60 მლნ.
25,35 მლნ.
25,35 მლნ.
Research and development expenses
1,54 მლნ.
1,54 მლნ.
1,14 მლნ.
1,14 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,65 მლნ.
19,65 მლნ.
24,36 მლნ.
24,36 მლნ.
Operating expense
20,93 მლნ.
20,93 მლნ.
25,29 მლნ.
25,29 მლნ.
Total operating expenses
51,52 მლნ.
51,52 მლნ.
50,64 მლნ.
50,64 მლნ.
Operating income
-3,76 მლნ.
-3,76 მლნ.
-10,72 მლნ.
-10,72 მლნ.
Other non operating income
-323,00 ათ.
-323,00 ათ.
-141,50 ათ.
-141,50 ათ.
EBT including unusual items
-2,95 მლნ.
-2,95 მლნ.
-18,11 მლნ.
-18,11 მლნ.
EBT excluding unusual items
-7,26 მლნ.
-7,26 მლნ.
-14,29 მლნ.
-14,29 მლნ.
Income tax expense
-1,07 მლნ.
-1,07 მლნ.
372,00 ათ.
372,00 ათ.
Effective tax rate
36,20%
36,20%
-2,05%
-2,05%
Other operating expenses
-259,50 ათ.
-259,50 ათ.
-212,50 ათ.
-212,50 ათ.
Net income
-1,88 მლნ.
-1,88 მლნ.
-18,48 მლნ.
-18,48 მლნ.
Net profit margin
-3,94%
-3,94%
-46,29%
-46,29%
Earnings per share
-
-
-
-
Interest and investment income
649,50 ათ.
649,50 ათ.
917,00 ათ.
917,00 ათ.
Interest expense
-3,55 მლნ.
-3,55 მლნ.
-3,94 მლნ.
-3,94 მლნ.
Net interest expenses
-2,90 მლნ.
-2,90 მლნ.
-3,02 მლნ.
-3,02 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,06 მლნ.
-2,06 მლნ.
-7,43 მლნ.
-7,43 მლნ.
Gain or loss from assets sale
53,00 ათ.
53,00 ათ.
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები